Product Datasheet  
LATS1/2 Antibody  
Catalog Number: 33232  
Technical:tech@swbio.com  
Information:info@swbio.com  
Description  
  • host_species:  
  • Rabbit
  • Amount:  
  • 100μgμg
  • Swiss-Prot No.:  
  • Swiss-Prot: O95835/Q9NRM7
    NCBI Gene ID: 9113/26524
  • Form of Antibody:  
  • Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
  • Storage:  
  • Store at -20˚C
  • Immunogen:  
  • Synthesized peptide derived from Internal of human LATS1/2.
  • reactivity:  
  • Hu
  • appl_detail:  

  • Immunohistochemistry: 1:50~1:100

  • other_names:  
  • EC 2.7.11.1; Large tumor suppressor 1; WARTS;
  • Purification:  
  • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
  • Specificity:  
  • The antibody detects endogenous levels of total LATS1/2 protein.
  • Applications:  
  • IHC WB
  • Background:  
  • Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS1 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. Acts as a tumor suppressor which plays a critical role in maintenance of ploidy through its actions in both mitotic progression and the G1 tetraploidy checkpoint. Negatively regulates G2/M transition by down-regulating CDK1 kinase activity. Involved in the control of p53 expression. Affects cytokinesis by regulating actin polymerization through negative modulation of LIMK1. May also play a role in endocrine function.

    Tao W., Nat. Genet. 21:177-181(1999).
    Nishiyama Y., FEBS Lett. 459:159-165(1999).
    The MGC Project Team, Genome Res. 14:2121-2127(2004).




 
© Signalway Biotechnology All Rights Reserved.